Mitsubishi UFJ Asset Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,981
Closed -$94K 1586
2023
Q3
$94K Hold
23,981
﹤0.01% 1088
2023
Q2
$243K Buy
23,981
+6,722
+39% +$71.2K ﹤0.01% 1018
2023
Q1
$176K Buy
17,259
+1,230
+8% +$14.1K ﹤0.01% 1036
2022
Q4
$149K Buy
+16,029
New +$226K ﹤0.01% 1054
2022
Q2
Sell
-9,364
Closed -$160K 1204
2022
Q1
$160K Buy
9,364
+1,089
+13% +$18.5K ﹤0.01% 1086
2021
Q4
$221K Buy
+8,275
New +$258K ﹤0.01% 1067

Other funds holding TSVT

Mitsubishi UFJ Asset Management's TSVT Position: Q4 2023 in Review

Mitsubishi UFJ Asset Management sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 23,981 shares — an estimated $94K sold.

Mitsubishi UFJ Asset Management first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $243K in Q2 2023. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Mitsubishi UFJ Asset Management reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 23,981 2seventy bio shares in Q4 2023, an estimated $94K.
  • Mitsubishi UFJ Asset Management first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Asset Management's 2seventy bio position peaked at $243K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2023, filed 8 Feb 2024.